Consistent with our results in humans, a type I IFN signaling pathway was identified among the top upregulated gene networks in a patient harboring a dominant activating mutation in NLRC4 (T337S), which leads to macrophage activation syndrome (5). Here, NLRC4 is linked to macrophage activation syndrome.